8 results
10-Q
2023 Q1
MLYS
Mineralys Therapeutics Inc
15 May 23
Quarterly report
5:25pm
of the grant or modification. The Company estimates the fair value of its stock option awards using the Black-Scholes option pricing model, which
DRS/A
mpccbgesx4s10yrtxszu
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
0hp2q kbf64
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
o5gukh
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next